We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GAO: FDA Slow to Phase Out Use of Unproven COVID-19 Tests in Labs
GAO: FDA Slow to Phase Out Use of Unproven COVID-19 Tests in Labs
The FDA was slow to begin phasing out its policy that allowed the emergency authorization of hundreds of COVID-19 tests before their efficacy was proven.